Recombinant Human NRP1 Protein (Phe22-Lys852), C-hFc-tagged
Product Description
Cat
IMP-9596
Official Symbol
NRP1
Product Overview
Recombinant human Neuropilin-1 protein (Phe22-Lys852) with a Human IgG1 (Pro100-Lys330) Fc tag at C-terminus was expressed in Human embryonic kidney cell.
Description
This gene encodes one of two neuropilins, which contain specific protein domains which allow them to participate in several different types of signaling pathways that control cell migration. Neuropilins contain a large N-terminal extracellular domain, made up of complement-binding, coagulation factor V/VIII, and meprin domains. These proteins also contains a short membrane-spanning domain and a small cytoplasmic domain. Neuropilins bind many ligands and various types of co-receptors; they affect cell survival, migration, and attraction. Some of the ligands and co-receptors bound by neuropilins are vascular endothelial growth factor (VEGF) and semaphorin family members. This protein has also been determined to act as a co-receptor for SARS-CoV-2 (which causes COVID-19) to infect host cells.
Expression System
HEK293
Species
Human
Tag
C-hFc
Predicted N Terminal
Phe22
Form
Lyophilized from a 0.2 μm filtered solution in PBS.
Molecular Mass
Predicted Molecular Mass: 120 kDa
SDS-PAGE: 117-131 kDa, under reducing conditions
Protein length
Phe22-Lys852
Bio-activity
Measured by its binding ability in a functional ELISA. When Recombinant Human Neuripilin-1 Fc Chimera is immobilized at 1 μg/mL (100 μL/well), Recombinant Human VEGF 165 binds with an ED50 of 0.25-1.5 ng/mL.
Endotoxin
<0.10 EU/μg of the protein by the LAL method.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
Notes
Disulfide-linked homodimer
Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, -20 to -70 centigrade under sterile conditions after reconstitution.
Reconstitution
Reconstitute at 500 μg/mL in PBS.
SDS-PAGE
SDS-PAGE

Bioactivity-ELISA 1
Binding Activity

Measured by its binding ability in a functional ELISA. When Recombinant Human Neuripilin-1 Fc Chimera is immobilized at 1 μg/mL (100 μL/well), Recombinant Human VEGF 165 binds with an ED50 of 0.25-1.5 ng/mL.

Data Sheet MSDS
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Online Inquiry
Contact Info